Stull, Stull & Brody Announces Investigation on Behalf of Shareholders of GenTek, Inc.

Attorney Advertising. Notice is hereby given that Stull, Stull & Brody has commenced an investigation on behalf of shareholders of GenTek, Inc. (“GenTek” or the “Company”) (Nasdaq: GETI) for possible breaches of fiduciary duty and other violations of state law in connection with an agreement by the Company’s Board of Directors to sell all of the Company’s outstanding shares of common stock to a wholly-owned subsidiary of American Securities LLC at a price of $38 per share in cash.

If you own common stock of GenTek and wish to obtain additional information about this matter, please contact Stull, Stull & Brody at the toll-free number listed below. Stull, Stull & Brody has litigated many class actions for violations of securities laws and breaches of fiduciary duties on behalf of defrauded investors over the past 40 years and has obtained court approval of substantial settlements on numerous occasions.

The current investigation concerns the proposed price offered to shareholders and the process by which GenTek’s Board of Directors is addressing the proposed transaction. For the second quarter 2009, the Company reported a 152% improvement in operating profit, as compared to the same prior-year period, as well as strong cash flows that have resulted in $59.8 million in cash on hand at the close of the most recent quarter. The focus of the investigation is on whether the GenTek’s Board of Directors breached their fiduciary duties to GenTek’s shareholders by agreeing to sell the Company at an unfair price and by agreeing to a $10 million termination fee that will all but ensure that no superior offer will be forthcoming.

If you wish to discuss this matter or have any questions concerning this notice or your rights or interests with respect to this matter, please contact Aaron Brody, Esq. at Stull, Stull & Brody by calling 1-800-337-4983 or 1-212-687-7230, or by email to ssbny@aol.com or by writing to Stull, Stull & Brody, 6 East 45th Street, New York, NY 10017.

Attorney advertising. Prior results do not guarantee a similar outcome.

Gentek (NASDAQ:GETI)
과거 데이터 주식 차트
부터 12월(12) 2024 으로 1월(1) 2025